[go: up one dir, main page]

CU23673B7 - ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE - Google Patents

ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE

Info

Publication number
CU23673B7
CU23673B7 CU20070150A CU20070150A CU23673B7 CU 23673 B7 CU23673 B7 CU 23673B7 CU 20070150 A CU20070150 A CU 20070150A CU 20070150 A CU20070150 A CU 20070150A CU 23673 B7 CU23673 B7 CU 23673B7
Authority
CU
Cuba
Prior art keywords
dosage forms
pharmaceutical dosage
modified release
solid pharmaceutical
oral route
Prior art date
Application number
CU20070150A
Other languages
Spanish (es)
Other versions
CU20070150A7 (en
Inventor
Klaus Benke
Jan-Olav Henck
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Priority to CU20070150A priority Critical patent/CU23673B7/en
Publication of CU20070150A7 publication Critical patent/CU20070150A7/en
Publication of CU23673B7 publication Critical patent/CU23673B7/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a formas de dosificación farmacéutica sólidas administrables por vía oral que contienen 5-cloro-N({(5S)-2oxo-3-[4-(3-oxo-4morfolinil)fenil]-1,3-oxazolidin-5-il}metil)-2-tiofenocarboxamida con liberación modificada, así como a procedimientos para su fabricación, a su uso como medicamentos, a su uso para la profilaxis, la profilaxis secundaria y/o el tratamiento de enfermedades, así como a su uso para la fabricación de un medicamento para la profilaxis, la profilaxis secundaria y/o el tratamiento de enfermedades.The present invention relates to solid, orally administrable pharmaceutical dosage forms containing 5-chloro-N ({(5S) -2oxo-3- [4- (3-oxo-4morpholinyl) phenyl] -1,3-oxazolidin -5-yl} methyl) -2-thiophenecarboxamide with modified release, as well as procedures for its manufacture, its use as medicines, its use for prophylaxis, secondary prophylaxis and / or treatment of diseases, as well as a its use for the manufacture of a medicament for prophylaxis, secondary prophylaxis and / or the treatment of diseases.

CU20070150A 2007-06-25 2007-06-25 ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE CU23673B7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20070150A CU23673B7 (en) 2007-06-25 2007-06-25 ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20070150A CU23673B7 (en) 2007-06-25 2007-06-25 ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE

Publications (2)

Publication Number Publication Date
CU20070150A7 CU20070150A7 (en) 2009-09-08
CU23673B7 true CU23673B7 (en) 2011-05-27

Family

ID=44280827

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20070150A CU23673B7 (en) 2007-06-25 2007-06-25 ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE

Country Status (1)

Country Link
CU (1) CU23673B7 (en)

Also Published As

Publication number Publication date
CU20070150A7 (en) 2009-09-08

Similar Documents

Publication Publication Date Title
AR052843A1 (en) PHARMACEUTICAL DOSAGE METHODS ADMINISTRABLE SOLIDS BY ROUTE WITH MODIFIED RELEASE
ECSP088339A (en) SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF ACTIVE PRINCIPLE
ECSP066584A (en) PROCEDURE FOR THE PRODUCTION OF A SOLID PHARMACEUTICAL COMPOSITION OF ORAL ADMINISTRATION
CO6460769A2 (en) NEW VIRAL REPLICATION INHIBITORS
DOP2011000218A (en) SULFONAMIDE DERIVATIVES
CL2008003822A1 (en) Compounds derived from n1- (2-thiazolyl) -1,2-dicarboxamide pyrrolidine; preparation procedure; pharmaceutical composition; pharmaceutical combination; and use for the treatment of diseases ameliorated by phosphatidylinositol-3-kinase inhibition, such as cancer.
UY33246A (en) TIENOPIRIMIDINES CONTAINING CYCLLOQUAL FOR PHARMACEUTICAL COMPOSITIONS
UY33241A (en) ? Tienopyrimidines containing heterocycloalkyl for pharmaceutical compositions ?.
UA112055C2 (en) SALTS 4- [2 - [[5-METHYL-1- (2-NAPHTHALINYL) -1H-PYRAZOL-3-yl] OXY] ETHYL] MORPHOLINE
CO2018005842A2 (en) Pharmaceutical composition comprising a potent urat 1 inhibitor
CU20140152A7 (en) PHARMACEUTICAL ADMINISTRATION FORMS INCLUDING 5-CHLORINE-N - ({(5S) -2-OXO-3- [4- (3-OXO-4-MORFOLINIL) PHENYL] -1,3-OXAZOLIDIN-5-IL} METHYL ) -2-THIOFENCARBOXAMIDE
DK1987026T3 (en) Aminoacyl prodrug derivatives and drugs for the treatment of thromboembolic diseases
EA201200485A1 (en) ORAL FALLING PHARMACEUTICAL DRUG FORM CONTAINING AIPIPRAZOL
UY33529A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY AND INFLAMMATORY DISEASES?
WO2012080184A3 (en) Liquid pharmaceutical compositions which can be administered orally and contain 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophene carboxamide
CU23673B7 (en) ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE
UY29305A1 (en) ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE
DOP2005000265A (en) PHARMACEUTICAL DOSAGE FORM ADMINISTRABLE SOLIDS BY ORAL ROUTE WITH MODIFIED RELEASE.
EA200970125A1 (en) APPLICATION OF FLUMAZENYL IN THE MANUFACTURE OF A MEDICINE FOR THE TREATMENT OF DEPRESSIVE DISORDERS
UY28628A1 (en) PROCEDURE FOR THE PREPARATION OF AN ORALLY ADMINISTRABLE SOLID PHARMACEUTICAL COMPOSITION
EA200900173A1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL APPLICATION
NO20081982L (en) Solid, orally administrable pharmaceutical dosage forms with rapid release of active compound

Legal Events

Date Code Title Description
FG Grant of patent
FD Lapse (for not paying fees)